Supernus Pharmaceuticals buy marge
Start price
21.06.15
/
50%
€14.50
Target price
22.07.15
€18.00
Performance (%)
24.25%
End price
22.07.15
€18.02
Summary
This prediction ended on 22.07.15 with a price of €18.02. The BUY prediction by marge finished with a performance of 24.25%. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Supernus Pharmaceuticals | -1.600% | -1.600% | -8.889% | -7.519% |
| iShares Core DAX® | 0.238% | -2.265% | 13.679% | 14.917% |
| iShares Nasdaq 100 | -0.304% | 5.808% | 34.538% | 52.796% |
| iShares Nikkei 225® | 2.271% | 1.577% | 9.436% | 5.432% |
| iShares S&P 500 | -0.296% | 4.447% | 28.577% | 47.257% |
Comments by marge for this prediction
In the thread Supernus Pharmaceuticals diskutieren
Supernus
Aus meinem Langfristportofolio mit den Large-cap biotechs:
1.Gilead Science (40%)
2. Amgen (15%)
3. Celgene (25%),
und den smaller-cap biotechs:
Isis Pharmaceuticals, ChemoCentryx, Acceleron,
Portola Pharmaceuticals, Cempra, Supernus mit anteiliger Gesamtgewichtung von 20%
Nachfragen zu den einzelnen Werten beantworte ich gerne.
(Vom Mitglied beendet)